Results 91 to 100 of about 2,689 (160)

Health workers' adoption of digital health technology in low- and middle-income countries: a systematic review and meta-analysis. [PDF]

Bull World Health Organ
Wang M, Huang K, Li X, Zhao X, Downey L, Hassounah S, Liu X, Jin Y, Ren M.   +8 more
europepmc   +1 more source

[Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy]. [PDF]

Probl Endokrinol (Mosk), 2022
Nagaeva EV.
europepmc   +1 more source

[Polycystic ovary syndrome: new and promising treatment methods]. [PDF]

Probl Endokrinol (Mosk)
Gasieva DM, Sheremetyeva EV, Kalashnikova MF, Dzgoeva FK, Alborova ET.   +4 more
europepmc   +1 more source

[The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice]. [PDF]

Probl Endokrinol (Mosk)
Sviridenko NY, Ananicheva EV, Gershevich VM, Grusha YO, Chepilev KA, Surov AV, Yurgel VV, Shchukin KS, Bessmertnaya EG, Bilevich OA.   +9 more
europepmc   +1 more source

[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]

Probl Endokrinol (Mosk), 2022
Khovasova NO, Dudinskaya EN, Naumov AV, Tkacheva ON, Machekhina LV, Onuchina JS.   +5 more
europepmc   +1 more source

Treatment of children and adolescents with post-traumatic stress in humanitarian crises: systematic review and meta-analysis. [PDF]

Bull World Health Organ
Douglas FE, Shroff C, Meiser-Stedman R.
europepmc   +1 more source

[The impact of carbohydrate metabolism disorders on the early and long-term clinical outcomes of patients with COVID-19 according to the AKTIV and AKTIV 2 registries]. [PDF]

Probl Endokrinol (Mosk), 2023
Salukhov VV, Arutyunov GP, Tarlovskaya EI, Batluk TI, Bashkinov RA, Samus IV, Melnikov ES, Trubnikova MA, Arutyunov AG.   +8 more
europepmc   +1 more source

[Definitive treatment of Graves' disease in children]. [PDF]

Probl Endokrinol (Mosk), 2022
Ivannikova TE, Shiryaeva TY, Nagaeva EV, Sheremeta MS, Brovin DN, Bezlepkina OB.   +5 more
europepmc   +1 more source

[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]. [PDF]

Probl Endokrinol (Mosk)
Cheplyaeva NI, Babkov DA, Lukyanov AV, Danilov RD, Spasov AA.   +4 more
europepmc   +1 more source

[Endocrine disorders in patients with transfusion-dependent hereditary anemias]. [PDF]

Probl Endokrinol (Mosk), 2022
Vitebskaya AV, Bugakova ES, Pisareva EA, Tikhonovich YV.   +3 more
europepmc   +1 more source